These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 39133547)

  • 1. A study of antigen selection by extracellular vesicles as vaccine candidates against
    Ji L; Ruan H; Fu Y; Xiong S
    J Med Microbiol; 2024 Aug; 73(8):. PubMed ID: 39133547
    [No Abstract]   [Full Text] [Related]  

  • 2. Differential proteomics approach to identify putative protective antigens of Mycobacterium tuberculosis presented during early stages of macrophage infection and their evaluation as DNA vaccines.
    Sharma S; Rajmani RS; Kumar A; Bhaskar A; Singh A; Manivel V; Tyagi AK; Rao KV
    Indian J Exp Biol; 2015 Jul; 53(7):429-39. PubMed ID: 26245027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting Mycobacterium tuberculosis Tumor Necrosis Factor Alpha-Downregulating Genes for the Development of Antituberculous Vaccines.
    Olsen A; Chen Y; Ji Q; Zhu G; De Silva AD; Vilchèze C; Weisbrod T; Li W; Xu J; Larsen M; Zhang J; Porcelli SA; Jacobs WR; Chan J
    mBio; 2016 May; 7(3):. PubMed ID: 27247233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracellular vesicles released by J774A.1 macrophages reduce the bacterial load in macrophages and in an experimental mouse model of tuberculosis.
    García-Martínez M; Vázquez-Flores L; Álvarez-Jiménez VD; Castañeda-Casimiro J; Ibáñez-Hernández M; Sánchez-Torres LE; Barrios-Payán J; Mata-Espinosa D; Estrada-Parra S; Chacón-Salinas R; Serafín-López J; Wong-Baeza I; Hernández-Pando R; Estrada-García I
    Int J Nanomedicine; 2019; 14():6707-6719. PubMed ID: 31692512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chimeric antigen carried by extracellular vesicles induces stronger protective immunity against Mycobacterium tuberculosis infection.
    Ji L; Fu Y; Xiong S
    Immunobiology; 2024 Sep; 229(5):152834. PubMed ID: 38968836
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Mohammadzadeh R; Ghazvini K; Farsiani H; Soleimanpour S
    Crit Rev Microbiol; 2021 Feb; 47(1):13-33. PubMed ID: 33044878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracellular Vesicles Released from
    Alvarez-Jiménez VD; Leyva-Paredes K; García-Martínez M; Vázquez-Flores L; García-Paredes VG; Campillo-Navarro M; Romo-Cruz I; Rosales-García VH; Castañeda-Casimiro J; González-Pozos S; Hernández JM; Wong-Baeza C; García-Pérez BE; Ortiz-Navarrete V; Estrada-Parra S; Serafín-López J; Wong-Baeza I; Chacón-Salinas R; Estrada-García I
    Front Immunol; 2018; 9():272. PubMed ID: 29520273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunological characterization of chimeras of high specificity antigens from Mycobacterium tuberculosis H37Rv.
    Fatma F; Tripathi DK; Srivastava M; Srivastava KK; Arora A
    Tuberculosis (Edinb); 2021 Mar; 127():102054. PubMed ID: 33550109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative transcriptomic analysis of THP-1-derived macrophages infected with Mycobacterium tuberculosis H37Rv, H37Ra and BCG.
    Pu W; Zhao C; Wazir J; Su Z; Niu M; Song S; Wei L; Li L; Zhang X; Shi X; Wang H
    J Cell Mol Med; 2021 Nov; 25(22):10504-10520. PubMed ID: 34632719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthetic Long Peptide Derived from Mycobacterium tuberculosis Latency Antigen Rv1733c Protects against Tuberculosis.
    Coppola M; van den Eeden SJ; Wilson L; Franken KL; Ottenhoff TH; Geluk A
    Clin Vaccine Immunol; 2015 Sep; 22(9):1060-9. PubMed ID: 26202436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity and protective efficacy of a fusion protein vaccine consisting of antigen Ag85B and HspX against Mycobacterium tuberculosis infection in mice.
    Li Q; Yu H; Zhang Y; Wang B; Jiang W; Da Z; Xian Q; Wang Y; Liu X; Zhu B
    Scand J Immunol; 2011 Jun; 73(6):568-76. PubMed ID: 21323695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA vaccine with discontinuous T-cell epitope insertions into HSP65 scaffold as a potential means to improve immunogenicity of multi-epitope Mycobacterium tuberculosis vaccine.
    Wu M; Li M; Yue Y; Xu W
    Microbiol Immunol; 2016 Sep; 60(9):634-45. PubMed ID: 27531823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential Immunogenicity and Protective Efficacy Elicited by MTO- and DMT-Adjuvanted CMFO Subunit Vaccines against
    Ullah N; Hao L; Wu Y; Zhang Y; Lei Q; Banga Ndzouboukou JL; Lin X; Fan X
    J Immunol Res; 2020; 2020():2083793. PubMed ID: 32953889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunodominant
    Arora SK; Alam A; Naqvi N; Ahmad J; Sheikh JA; Rahman SA; Hasnain SE; Ehtesham NZ
    Front Immunol; 2020; 11():1199. PubMed ID: 32793184
    [No Abstract]   [Full Text] [Related]  

  • 15.
    Jia Q; Masleša-Galić S; Nava S; Horwitz MA
    mBio; 2022 Jun; 13(3):e0068722. PubMed ID: 35642945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exosomes carrying mycobacterial antigens can protect mice against Mycobacterium tuberculosis infection.
    Cheng Y; Schorey JS
    Eur J Immunol; 2013 Dec; 43(12):3279-90. PubMed ID: 23943377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection against Mycobacterium tuberculosis infection offered by a new multistage subunit vaccine correlates with increased number of IFN-γ+ IL-2+ CD4+ and IFN-γ+ CD8+ T cells.
    Wang X; Zhang J; Liang J; Zhang Y; Teng X; Yuan X; Fan X
    PLoS One; 2015; 10(3):e0122560. PubMed ID: 25822536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel tuberculosis DNA vaccine in an HIV-1 p24 protein backbone confers protection against Mycobacterium tuberculosis and simultaneously elicits robust humoral and cellular responses to HIV-1.
    Li X; Xu W; Xiong S
    Clin Vaccine Immunol; 2012 May; 19(5):723-30. PubMed ID: 22461526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity and vaccine potential of clinical isolate
    Kim H; Shin SJ
    Microbiol Spectr; 2024 Aug; 12(8):e0081924. PubMed ID: 38980025
    [No Abstract]   [Full Text] [Related]  

  • 20. Future Path Toward TB Vaccine Development: Boosting BCG or Re-educating by a New Subunit Vaccine.
    Gupta N; Garg S; Vedi S; Kunimoto DY; Kumar R; Agrawal B
    Front Immunol; 2018; 9():2371. PubMed ID: 30386336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.